Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Influence of SLC22A1 polymorphisms on ranitidine pharmacokinetics
ChiCTR-OCH-14004902Phase 4Completed
- Sponsor
- Pharmacogenetics Research Institute, Xiangya Hospital, Central South University
- Start
- Jul 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of ranitidine (6 arms), sponsored by Pharmacogenetics Research Institute, Xiangya Hospital, Central South University. Primary endpoint: Blood drug concentration. Started Jul 2014; status: completed.
02
Drugs
ranitidine
Beyond the preview
Go deeper on ChiCTR-OCH-14004902.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR-OCH-14004902.